What's new

Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised

Jun 3, 2025 - 11:00
 0
Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Atazanavir Krka, ataza...

Next Article

Sizewell C nuclear power plant ‘could get go-ahead within weeks’

Related Posts

Human medicines European public assessment report (EPAR): Arexvy, Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Summary of opinion: NexGard Combo, 15/05/2025 Positive

Summary of opinion: NexGard Combo, 15/05/2025 Positive

May 16, 2025  0